3 Magnificent S&P 500 Dividend Stocks Down Roughly 26% to 60% to Buy and Hold ForeverThe Motley Fool • 08/13/25
KEYTRUDA® (pembrolizumab) plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free and Overall Survival and Pathologic Complete Response Rate for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After SurgeryBusiness Wire • 08/12/25
Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?Zacks Investment Research • 08/11/25
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8.5% (August 2025)Seeking Alpha • 08/02/25
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challengesWSJ • 08/01/25